期刊文献+

奥利司他的不良反应及安全应用 被引量:13

Adverse reations of orlistat and its rational application
原文传递
导出
摘要 奥利司他(orlistat)是一种新的局部作用的减肥药,为胃肠道脂肪酶抑制剂,能减少脂肪的吸收使体重减轻。奥利司他的常见不良反应为胃肠道紊乱,少见不良反应为肝损害、过敏反应等。本文目的是为临床合理应用奥利司他提供依据。 Orlistat, a novel non-systemic treatment for obesity, is a gastrointestinal lipase inhibitor which decreases intestinal fat absorption and promotes loss of weight. The common adverse reactions of orlistat are gastrointestinal disturbances, uncommon adverse reactions are liver damage, anaphylactic reaction, etc. The purpose of this paper is to provide basis for rational application of orlistat in clinical practice.
作者 訾梅 李祥霞
出处 《药物不良反应杂志》 2007年第3期182-185,共4页 Adverse Drug Reactions Journal
关键词 奥利司他 不良反应 安全用药 orlistat adverse reactions rational application
  • 相关文献

参考文献27

  • 1Finer N, James WP, Kopelman PG, et al. One year treatment of obesity: a randomized, double blind, placebo controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor[J]. Int J Obes Relat Metab Disord, 2000, 24(3): 306-313.
  • 2Malhotra S, McElroy SL. Orlistat misuse in bulimia nervosa[J]. Am J Psychiatry, 2002, 159(3): 492-493.
  • 3Heck AM, Calis KA, McDuffie JR, et al. Additive gastrointestinal effects with concomitant use of olestra and orlistat[J]. Ann Pharmacother, 2002, 36(6): 1003-1005.
  • 4Montero JL, Muntane J, Fraga E, et al. Orlistat associated subacute hepatic failure[J]. J Hepatol, 2001, 34(1): 173.
  • 5Thurairajah PH, Syn WK, Neil DA, et al. Orlistat (Xenical) induced subacute liver failure [J]. Eur J Gastroen Hepatol, 2005, 17(12): 1437-1438.
  • 6Umemura T, Ichijo T, Matsumoto A, et al. Severe hepatic injury caused by orlistat[J]. Am J Med, 2006, 119(8): e7.
  • 7Gonzalez Gay MA, Garcia Porrua C, Lueiro M, et al. Orlistat induced cutaneous leukocytoclastic vasculitis[J]. Arthritis Rheum, 2002, 47(5): 567.
  • 8Sergeant A, Milne G, Shaffrali F. Lichenoid eruption associated with orlistat. Bfit J Dermatol, 2006, 154 (5): 1020- 1021.
  • 9Azar ST, Zantout MS. Diabetic ketoacidosis associated with orlistat treatment[J]. Diabetes Care, 2001, 24(3): 602.
  • 10Packard KA, Wurdeman RL, Reyes AP. Constipation, polyuria, polydipsia, and edema associated with orlistat [J]. Ann Pharmacother, 2002, 36(8): 1168-1170.

二级参考文献4

  • 1Ge L,Asia Pacific J Clin Nutr,1997年,6卷,175页
  • 2方圻,中华心血管病杂志,1997年,25卷,169页
  • 3Chan J M,Diabetes Care,1994年,17卷,961页
  • 4方圻,王钟林,宁田海,邵耕,陈在嘉,陆宗良,李健斋,林传骧,周北凡,诸骏仁,诸永康,陶萍,陶寿淇,龚兰生,顾复生,游凯,戴玉华.血脂异常防治建议[J].中华心血管病杂志,1997,25(3):169-175. 被引量:3067

共引文献45

同被引文献116

引证文献13

二级引证文献97

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部